Halozyme Therapeutics Inc
NASDAQ:HALO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
47.91
78.28
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
HALO Price Targets Summary
Halozyme Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
HALO
is 78.67 USD
with a low forecast of 58.58 USD and a high forecast of 96.6 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HALO's stock price target?
Price Target
78.67
USD
According to Wall Street analysts, the average 1-year price target for
HALO
is 78.67 USD
with a low forecast of 58.58 USD and a high forecast of 96.6 USD.
What is Halozyme Therapeutics Inc's Revenue forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Halozyme Therapeutics Inc's revenue is
25%.
The projected
CAGR
for the next 4 years is
19%.
What is Halozyme Therapeutics Inc's Operating Income forecast?
Projected CAGR
24%
The
compound annual growth rate
of Halozyme Therapeutics Inc's operating income for the next 4 years is
24%.
What is Halozyme Therapeutics Inc's Net Income forecast?
Projected CAGR
29%
The
compound annual growth rate
of Halozyme Therapeutics Inc's net income for the next 4 years is
29%.
